Industry - acib

FROM IDEA TO INNOVATION

acib has built up a network of numerous small, middle and large sized industry partners coming from several sectors of industrial biotechnology. Most of them joined the COMET consortium, but – as COMET is temporary and monetary limited – acib also has opportunities for alternate collaboration possibilities.

An attractive offer for our stakeholders from industry is the academic partner network, which allows industrial organizations to consume R&D activities from a tailored research expertise portfolio coming from currently 53 scientific partners.

acib AS TARGETED-RESEARCH-HUB

acib’s position as a targeted-research-hub for industrial biotechnology will be further developed. In combining all partners and networks in a new contractual acib partner network, acib is able to fulfill its mission of connecting the worlds from academia and industry for innovation and science-know-how. Thus acib is a one-stop-shop and ideal partner for Open Innovation.

CURRENT OFFERS – RESEARCH MARKET PLACE

acib offers new technologies, expertise and project concepts. Please keep up-to-date with our latest offers by subscribing to our newsletter. For further information please contact Martin Trinker.

43 / PROJECT OFFER

Rainbow Cell Technologies

3.04.2019

42 / PROJECT OFFER

Fighting Biofilms

12.02.2019

41 / PROJECT OFFER

CO₂-Recycling and Biopolymers

09.01.2019

40 / PROJECT OFFER

(Micro)plastic degradation

09.01.2019

39 / PROJECT OFFER

Bioleaching / Bioremediation

09.01.2019

38 / PROJECT OFFER

Enzyme discovery and development for polymer processing

13.12.2017

37 / PROJECT OFFER

3D Phase Contrast Microscopy for Flow Cytometry

13.12.2017

36 / PROJECT OFFER

Improving the immunogenicity of vaccines

13.12.2017

35 / TECHNOLOGY OFFER

Up-regulation of protein expression through use of RNA polymerase binding aptamers (RAPS)

21.11.2017

34 / PROJECT OFFER

Making nanoparticles more stable for biological environments

20.11.2017

33 / SERVICE OFFER

Smart library approaches employing the BioXP^TM 3200 platform

13.11.2017

32 / PROJECT OFFER

Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry

13.06.2017

31 / PROJECT OFFER

Project on Antibacterial Antibiotic Discovery and Development

13.06.2017

30 / CO-DEVELOPMENT OFFER

Inhibition of gene expression from “foreign DNA”

13.06.2017

29 / PROJECT OFFER

BioF&F – Biotechnological production of Flavor & Fragrance compounds

30.03.2017

28 / PROJECT OFFER

BOSS – Biotechnological Optimizations by Selection Systems

29.03.2017

27 / PROJECT OFFER

Biocatalytic methylation and demethylation of phenol derivatives

24.03.2017

26 / PROJECT OFFER

Lactic Acid Production

25 / PROJECT OFFER

Biorefinery Solutions

10.03.2017

24 / PROJECT OFFER

Photo-BioPolymers

10.03.2017

23 / CO-DEVELOPMENT OFFER

GISS – Gastro Intestinal Simulation System

22 / TECHNOLOGY OFFER

Compact and optimized metabolic pathway design in yeasts

16.02.2017

21 / SERVICE OFFER

Assembly of multi-part DNA constructs

26.01.2017

20 / SERVICE OFFER

Metabolomics

19.01.2017

19 / SERVICE OFFER

13-C labeled metabolite extract

19.01.2017

18 / PROJECT OFFER

Towards the next generation of industrial bioethanol production

19.01.2017

17 / PROJECT OFFER

Project offer: Towards the Next Generation of Lignocellulose-Based Industrial Biomanufacturing

19.01.2017

16 / PROJECT OFFER

Biotechnological synthesis of natural insect repellents

17.01.2017

15 / PROJECT OFFER

Continuous biocatalysis using liquid membrane technology

13.12.2016

14 / SERVICE OFFER

Bioinformatics

13.12.2016

13 / COMPETENCE OFFER

Biocatalytic Synthesis and Enzyme Technology

18.11.2016

12 / PROJECT OFFER

Enzymatic Alkene Cleavage

28.10.2016

11 / PROJECT OFFER

Biotechnological preparation of chitin and chitosan from shrimp shell waste

25.10.2016

10 / TECHNOLOGY OFFER

3D Enzyme Search

9 / PROJECT OFFER

Synthesis of bio-based resveratrol analogues

23.08.2016

8 / PROJECT OFFER

Combinatorial pathway assembly for Green Chemistry

26.07.2016

7 / SERVICE OFFER

Directed modification of proteins using unnatural amino acids

26.07.2016

6 / CO-DEVELOPMENT OFFER

Drug Resistance

18.07.2016

5 / TECHNOLOGY OFFER

Novel Hydroxynitrile Lyases

05.07.2017

4 / PROJECT OFFER

Antibacterial Antibiotic Discovery and Development – AntiBac

20.06.2016

3 / PROJECT OFFER

Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry – BacTech

1.06.2016

2 / TECHNOLOGY OFFER

Biocatalytic Friedel-Crafts Acylations

25.05.2016

1 / TECHNOLOGY OFFER

Nanomembranes

11.02.2016

“The acib collaboration provides an important contribution to Sandoz’s new technology evaluation & development programs.”

Dr. Sascha Keller / Head of Downstream Process Developement Sandoz
“Teaming up with acib has allowed us to be active at the cutting edge of CHO Cell Engineering and we are delighted to work with a highly devoted and skilled team with the aim to reduce future production costs for therapeutic proteins.”

Daniel Ivansson / Research Engineer Strategic Technologies GE Healthcare
“Our research and development progress would have been impossible without the collaboration with acib. acib complements our expertise to create a world class laboratory that can execute experiments at a high level. And, when we go to share results, acib’s stellar reputation ensure others have confidence in our data.”

Edward Eveleth / Chairman HocusLocus
“Our acib partners … are doing a thorough work. They pursue the project with diligence and a good sense for focusing on the important issues to be solved. It is a pleasure to collaborate with such a competent team and see continuous progress in achieving the project’s goals.”

Dr. Judith Wahrheit / Contract Research Biocrates
“While having grown to a large organization, acib still provides a highly professional and responsive collaborative research environment capable of quickly reacting to specific project needs.”

Dr. Peter Pöchlauer / Patheon Austria GmbH & Co KG
“We are working with acib since 2012. The results are exceeding our expectations and thus increase our competitiveness in the international biotechnology-market. We value the high competence and expertise of acib scientists, as well as the open and constructive discussions marked by trust and leading to pioneering innovations.”

Otto Kanzler / CEO Chorus
“acib is the foundation of our collaboration strategy in Austria. The projects we undertake within the framework in both Vienna/Tulln and Graz are essential to our innovation strategy. The quality and continuity of the programs are first rate while the overall context and connectivity that one experiences in parallel add a great deal to the experience.”

Michael Burnet / Managing Director Synovo
“acib is a very important R&D partner for Clariant Group Biotechnology in the field of academic cooperation and was chosen because of its specific expertise in Clariant’s fields of interest and current activities. acib provides research expertise which is at the forefront of experimental R&D state of the art, enabling up-to-date research work. acib has broad expertise in various fields of industrial biotechnology (strategic fit to industry needs).”

Dr. Georg Schirrmacher / Scientific Coordinator Clariant
“The collaboration with acib and its constituting body of experts in biotechnology in the framework of a funded R&D competence centre enables us to engage in high-risk potentially high-reward research. We greatly appreciate this opportunity.”

Dr. Patrick Lorenz / Head of Molecular Biology AB Enzymes
“As a pretty young company in the field of biolife-science we appreciate the close cooperation with the absolute experts of acib”

Peter Pucher / Head of R&D BDI – BioLife Science
“acib stands out due to the huge pool of multidisciplinary expertise and capabilities available for its industrial partners across the entire field of industrial biotechnology”

Dr. Thomas Purkarthofer / Head of Business Development Validogen (formerly VTU Technology)
“The acib collaboration enables rapid and straight-forward research on current requirements of the Roombiotic product pipeline. I personally recommend acib to biotech start-ups as powerful and reliable partner in challenging research projects.“

Dr. Daniel Treffer / CEO Roombiotic
“We joined our sister company AB Enzymes to collaborate with the acib teams from the Technical University of Vienna and BOKU and benefit from their renowned expertise in Trichoderma. Although at an early stage we are confident this collaboration will be fruitful for both sides.”

Dr. Jari Vehmaanperä / Global Head R&D Roal Oy
“The close and trusting collaboration with acib’s academic partners is a constant source of new and valuable stimulus for the development of innovative metabolic pathways and novel reactor designs for optimal performance of the functionalization of alkanes.”

Bastian Grund / Project Manager Evonik
“Our collaboration with acib has so far proven to be very productive and has resulted in a number of exciting technical applications. The scientific team members are highly qualified and really motivated to pursue their objectives.”

Dr. Christa Tauer / Head of Bio OpU Process Development Shire
“acib provides the right mix of scientific competence, goal-oriented flexibility and variety of specialist skills to perform ambitious research projects with both fundamental and application aspects in a fast and effective manner.”

Jürgen Felber / CEO IPUS
“The current cooperation with acib provides an essential and valuable contribution to improve our existing manufacturing process. The theoretical and practical knowledge provided by acib are key parameters that will bring our joint project to success. ”

Dr. Matthias Müllner / Head of Manufacturing Themis Bioscience
“acib facilitates in a highly professional and efficient manner the collaboration of people from two different worlds, academia and business. Knowing the different mindsets from both sides, acib is a valuable partner in helping to translate the needs and visions of both company and academic partners into a successful joint R&D cooperation.”

Gerald Ruppert / IP Manager Viscose Faser
“Thanks to acib we keep in touch with recent developments in a field of key relevance for our products.”

Dr. Dieter Moll / Research Director Biomin
“We are pleased with the long-lasting collaboration with acib. The open and creative atmosphere and the in general excellent results obtained have over the years contributed to the successful implementation of several industrial process in the production of chemical intermediates at DSM.”

Dr. Martin Schürmann / Principal Scientist DSM